SCHEMBL4688494

SCHEMBL4688494

Cc1cc(CN)cc(C)c1OCC(CO)CO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN4A P35499 11/20 0.42
S1PR1 P21453 1/20 0.40
S1PR3 Q99500 1/20 0.40
TSHR P16473 2/20 0.38
VDR P11473 4/20 0.36
LMNA P02545 2/20 0.36
SCN1A P35498 2/20 0.36
SCN5A Q14524 2/20 0.36
SCN9A Q15858 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
NFKB1 P19838 2/20 0.36
CYP2C9 P11712 1/20 0.36
KCNK3 O14649 1/20 0.36
CACNA1F O60840 1/20 0.36
KCNK2 O95069 1/20 0.36
GBA1 P04062 1/20 0.36
MAOA P21397 1/20 0.36
HTR2A P28223 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4688972 0.85 TSHR (0.47) SCN4AS1PR1S1PR3TSHRCYP1A2
SCHEMBL4684050 0.85 TSHR (0.47) SCN4AS1PR1S1PR3TSHRCYP1A2
SCHEMBL4550829 0.79 SCN4A (0.45) SCN4AS1PR1TSHRLMNASCN1A
Hydrochloric Acid SCHEMBL2717073 0.77 SCN4A (0.44) SCN4ATSHRLMNASCN1ASCN5A
SCHEMBL4688491 0.77 TSHR (0.42) SCN4AS1PR1S1PR3TSHRVDR
SCHEMBL4687492 0.77 HTR1A (0.42) SCN4AS1PR1S1PR3CYP1A2CYP2D6
SCHEMBL4685426 0.75 S1PR1 (0.39) SCN4AS1PR1S1PR3CYP1A2CYP2D6
SCHEMBL12936082 0.74 HTR2A (0.43) SCN4ATSHRHTR2AHTR2BGLA
SCHEMBL4687423 0.71 SCN4A (0.36) SCN4AS1PR1S1PR3SCN8AAPP
SCHEMBL837043 0.70 KMT2A (0.39) SCN4ACYP1A2CYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805163-B1 1,1A,5,5A-TETRAHYDRO-3-THIA-CYCLOPROPA[A]PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2008-10-01 EP claimed